Lead author of the STEP 1 trial, John Wilding, discusses the findings and what they may mean for the treatment of people with obesity.

Read the accompanying news story: http://bit.ly/3ai2ftT

View more on obesity and lifestyle interventions on Medicine Matters diabetes: http://bit.ly/2NhUdby